ALDX EBITDA Growth
Aldeyra Therapeutics Inc · EBITDA Growth
ALDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported55.91%period ending
ALDX TTM EBITDA YoY % (138.87% → 55.91%)
Year-over-year change
High-resolution chart · PNG
ALDX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 55.9118% | |
| 54.5864% | |
| 40.9613% | |
| 3.5996% | |
| -36.1851% | |
| -100.6866% | |
| -52.4515% | |
| 1.9269% | |
| 28.6821% | |
| 52.9434% | |
| 41.3897% | |
| 31.0694% | |
| 22.3004% | |
| 4.141% | |
| -7.7135% | |
| -21.644% | |
| -43.4464% | |
| -64.5036% | |
| -55.3006% | |
| -39.0926% | |
| 5.8918% | |
| 30.7897% | |
| 41.5479% | |
| 37.3285% | |
| 7.6159% | |
| -14.1015% | |
| -58.8518% | |
| -69.4818% | |
| -76.1893% | |
| -85.2547% | |
| -74.2979% | |
| -76.1703% | |
| -48.4933% | |
| -36.4989% | |
| -19.584% | |
| -8.9398% | |
| -16.8025% | |
| -26.3063% | |
| -55.1559% | |
| -81.686% | |
| -93.9845% | |
| -95.4728% | |
| -146.3765% | |
| -244.2766% | |
| -147.58% | |
| -142.5383% | |
| -136.7179% | |
| 138.8719% |